Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript

2025-07-31 21:55:29 ET

Bio-Rad Laboratories, Inc. (BIO)

Q2 2025 Earnings Conference Call

July 31, 2025 05:00 PM ET

Company Participants

Jonathan P. DiVincenzo - President & COO

Norman D. Schwartz - Chairman & CEO

Roop K. Lakkaraju - Executive VP & CFO

Yong Chung - Vice President of Investor Relations

Conference Call Participants

Brandon Couillard - Wells Fargo Securities, LLC, Research Division

Daniel Louis Leonard - UBS Investment Bank, Research Division

David Carter - Unidentified Company

Jack Meehan - Nephron Research LLC

Matthew Jay Stanton - Jefferies LLC, Research Division

Patrick Bernard Donnelly - Citigroup Inc., Research Division

Presentation

Operator

Thank you for standing by. My name is Gill, and I will be your operator for today's call. At this time, I would like to welcome each and every one of you to the Bio-Rad Second Quarter 2025 Results Conference Call and Webcast. [Operator Instructions]. It is now my pleasure to turn today's call over to Bio-Rad's Head of Investor Relations, Mr. Edward Chung. Please go ahead.

Yong Chung

Good afternoon, everyone, and thank you for joining us. Today, we will review the second quarter 2025 financial results and provide an update on key business trends for Bio-Rad. With me on the call today are Norman Schwartz, our Chief Executive Officer; Jon Jonathan DiVincenzo, President and Chief Operating Officer; and Roop Lakkaraju, Executive Vice President and Chief Financial Officer....

Read the full article on Seeking Alpha

For further details see: